Revenue, last quarter
$33.6M
+14.2% vs same quarter last year
Net income
−$14.7M
+17.7% vs same quarter last year
EPS, diluted
−$0.78
+22% vs same quarter last year
Operating cash flow
−$10.4M
−64.2% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $119.5M | −$81.7M |
| FY24 | $113.7M | −$128M |
| FY23 | $130.4M | −$172.8M |
| FY22 | $115.4M | −$163M |
| FY21 | $102.6M | −$131.9M |
| FY20 | $49.9M | −$121.5M |
| FY19 | $15.1M | −$68.3M |
| FY18 | $2M | −$49.8M |
| FY17 | - | - |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY25 | 39.1% | −55.8% | −68.3% |
| FY24 | 33.9% | −99.7% | −112.6% |
| FY23 | 22.2% | −130.2% | −132.5% |
| FY22 | 15.5% | −139.6% | −141.2% |
| FY21 | 7.4% | −127.2% | −128.6% |
| FY20 | −26.1% | −235.2% | −243.3% |
| FY19 | −118.1% | −466.3% | −453% |
| FY18 | −304.7% | −2320% | −2480.3% |
| FY17 | - | - | - |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | −$47.1M |
| FY24 | −$117.2M |
| FY23 | −$134.8M |
| FY22 | −$154.1M |
| FY21 | −$133.4M |
| FY20 | −$108.1M |
| FY19 | −$73.6M |
| FY18 | −$48.2M |
| FY17 | - |
- Outset Medical
- Healthcare median
Show the numbers
| Year | Outset Medical | Healthcare median |
|---|---|---|
| FY25 | −68.3% | −30.8% |
| FY24 | −112.6% | −47% |
| FY23 | −132.5% | −58% |
| FY22 | −141.2% | −80.4% |
| FY21 | −128.6% | −71.9% |
| FY20 | −243.3% | −62.2% |
| FY19 | −453% | −46.3% |
| FY18 | −2480.3% | −49.6% |
| FY17 | - | −45.9% |